NeuroTrigger News
2 articles
growth-positive
NeuroTrigger Received FDA 510(k) for its non-invasive muscle stimulation system (NTB)
NeuroTrigger has received 510(k) clearance from the US Food & Drug Administration (FDA) for its non-invasive muscle stimulation system (NTB). The system is designed to prevent or slow down disuse atrophy and muscle re-education to maintain or increase range of motion. The NTB system is portable, rechargeable, and user-friendly, and it includes a stimulator, a daily use/disposable electrode, and a mobile app. The company plans to conduct additional clinical trials in the U.S. and U.K. to extend the labeling claims of the device. Sales of the NeuroTrigger NTB System are expected to begin next year in the U.S.
Customers
growth-positive
Merage 45+ 2019 Startup Competition Winner: NeuroTrigger
NeuroTrigger, a company developing a system to improve the functioning of patients with facial nerve paralysis, has won this years Merage 45+ Entrepreneurs Competition. The company will receive $100,000 in funding and a place on the Merage Institutes Innovation Bridge Intensive Program in California. The program aims to help Israeli entrepreneurs strategize their products entry into the U.S. market. The competition is part of the Merage Institutes efforts to promote entrepreneurship and innovation among the 45+ community and strengthen connections between Israeli entrepreneurs and the U.S. markets.
Investment
